Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Katerina Rozkosova"'
Autor:
Lucie Pavelková, Eliška Táborská, Linn A. Syding, Klára Plačková, Ekaterina Simonova, Kamila Hladíková, Michal Hensler, Jan Laco, Vladimír Koucký, Michal Zábrodský, Jan Bouček, Marek Grega, Kateřina Rozkošová, Hana Vošmiková, Michael J. Halaška, Lukáš Rob, Ivan Práznovec, Miroslav Hodek, Milan Vošmik, Petr Čelakovský, Viktor Chrobok, Aleš Ryška, Lenka Palová-Jelínková, Radek Špíšek, Anna Fialová
Publikováno v:
Translational Oncology, Vol 41, Iss , Pp 101884- (2024)
The profile of the antitumor immune response is an important factor determining patient clinical outcome. However, the influence of the tissue contexture on the composition of the tumor microenvironments of virally induced tumors is not clearly under
Externí odkaz:
https://doaj.org/article/50bbd387d891473d807dcb409798a728
Autor:
Helena Hornychova, Marian Kacerovsky, Ivana Musilova, Lenka Pliskova, Helena Zemlickova, Adela Matejkova, Hana Vosmikova, Katerina Rozkosova, Petra Cermakova, Radka Bolehovska, Petr Halada, Bo Jacobsson, Jan Laco
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0207896 (2018)
OBJECTIVE:To evaluate the association between cervical human papillomavirus (HPV) infection at the time of admission and the presence of microbial invasion of the amniotic cavity (MIAC) and intra-amniotic inflammation (IAI) in women with preterm prel
Externí odkaz:
https://doaj.org/article/7fc851413d2d4359ba27502db92de40a
Autor:
Petr Halada, Marian Kacerovsky, Adela Matejkova, Jan Laco, Hana Vošmiková, Ivana Musilova, Helena Hornychova, Radka Bolehovska, Helena Zemlickova, Petra Čermáková, Lenka Pliskova, Katerina Rozkosova, Bo Jacobsson
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0207896 (2018)
PLoS ONE
PLoS ONE
Objective To evaluate the association between cervical human papillomavirus (HPV) infection at the time of admission and the presence of microbial invasion of the amniotic cavity (MIAC) and intra-amniotic inflammation (IAI) in women with preterm prel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2abd1c7c6f01e2ae48fbe4966f2e7bf
https://doi.org/10.1371/journal.pone.0207896
https://doi.org/10.1371/journal.pone.0207896
Autor:
Kamila Hladíková, Vladimír Koucký, Jan Bouček, Jan Laco, Marek Grega, Miroslav Hodek, Michal Zábrodský, Milan Vošmik, Kateřina Rozkošová, Hana Vošmiková, Petr Čelakovský, Viktor Chrobok, Aleš Ryška, Radek Špíšek, Anna Fialová
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-16 (2019)
Abstract Background Standard treatment of oropharyngeal squamous cell carcinoma (OPSCC) is associated with high morbidity, whereas immunotherapeutic approaches using PD-1:PD-L1 checkpoint blockade only show moderate response rates in OPSCC patients.
Externí odkaz:
https://doaj.org/article/6473f1a2484042f6bd01b538561e4160